| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $201,242 ) |
| 2024 | 2024 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 000 | 5 | 8/8/2024 | NON-COMPETING CONTINUATION | $201,242 |
|
| Issue Date FY: 2023 ( Subtotal = $176,138 ) |
| 2023 | 2023 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 002 | 4 | 7/26/2023 | NON-COMPETING CONTINUATION | $0 |
| 2023 | 2023 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 001 | 4 | 6/29/2023 | NON-COMPETING CONTINUATION | $176,138 |
| 2023 | 2022 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 000 | 3 | 5/3/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $360,000 ) |
| 2022 | 2022 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 001 | 3 | 8/12/2022 | NON-COMPETING CONTINUATION | $0 |
| 2022 | 2022 | HUMAN SERVICES VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 000 | 3 | 7/21/2022 | NON-COMPETING CONTINUATION | $360,000 |
|
| Issue Date FY: 2021 ( Subtotal = $360,000 ) |
| 2021 | 2021 | HUMAN SERVICES, VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 001 | 2 | 7/7/2021 | NON-COMPETING CONTINUATION | $360,000 |
| 2021 | 2020 | HUMAN SERVICES, VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 000 | 1 | 12/4/2020 | NEW | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $230,000 ) |
| 2020 | 2020 | HUMAN SERVICES, VERMONT AGENCY OF | 280 STATE DR | WATERBURY | VT | 05671 | WASHINGTON | USA | Food and Drug Administration Research | 000 | 1 | 9/8/2020 | NEW | $230,000 |
|
|